Subrata Kar1. 1. Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center at El Paso, Paul L. Foster School of Medicine, 4800 Alberta Ave, El Paso, TX, 79905, USA. skar762@aim.com.
Abstract
PURPOSE OF REVIEW: Percutaneous mechanical circulatory support devices (PMCSD) consist of the intra-aortic balloon pump (IABP), Impella (Abiomed Inc., Danvers, Massachusetts), Tandem Heart (Cardiac Assist, Inc., Pittsburgh, Pennsylvania), or extracorporeal membranous oxygenation (ECMO). They augment cardiac output, cardiac index, and cardiac power which allow the operator to mitigate hemodynamic perturbations during high-risk percutaneous coronary intervention (HR-PCI). This review discusses PMCSD and their contemporary literature. RECENT FINDINGS: Recent literature has substantiated the hemodynamic benefits of PMCSD in HR-PCI and cardiogenic shock, but no mortality benefit was found. As stent technology improves, PCI is expanding into high-risk cases in which PMCSD provide hemodynamic support allowing safe and complete revascularization.
PURPOSE OF REVIEW: Percutaneous mechanical circulatory support devices (PMCSD) consist of the intra-aortic balloon pump (IABP), Impella (Abiomed Inc., Danvers, Massachusetts), Tandem Heart (Cardiac Assist, Inc., Pittsburgh, Pennsylvania), or extracorporeal membranous oxygenation (ECMO). They augment cardiac output, cardiac index, and cardiac power which allow the operator to mitigate hemodynamic perturbations during high-risk percutaneous coronary intervention (HR-PCI). This review discusses PMCSD and their contemporary literature. RECENT FINDINGS: Recent literature has substantiated the hemodynamic benefits of PMCSD in HR-PCI and cardiogenic shock, but no mortality benefit was found. As stent technology improves, PCI is expanding into high-risk cases in which PMCSD provide hemodynamic support allowing safe and complete revascularization.
Authors: William W O'Neill; Neal S Kleiman; Jeffrey Moses; Jose P S Henriques; Simon Dixon; Joseph Massaro; Igor Palacios; Brijeshwar Maini; Suresh Mulukutla; Vladimír Dzavík; Jeffrey Popma; Pamela S Douglas; Magnus Ohman Journal: Circulation Date: 2012-08-30 Impact factor: 29.690
Authors: Jason C Kovacic; Annapoorna Kini; Subhash Banerjee; George Dangas; Joseph Massaro; Roxana Mehran; Jeffrey Popma; William W O'Neill; Samin K Sharma Journal: J Interv Cardiol Date: 2015-02 Impact factor: 2.279
Authors: Jin M Cheng; Corstiaan A den Uil; Sanne E Hoeks; Martin van der Ent; Lucia S D Jewbali; Ron T van Domburg; Patrick W Serruys Journal: Eur Heart J Date: 2009-07-18 Impact factor: 29.983
Authors: Simon R Dixon; José P S Henriques; Laura Mauri; Krischan Sjauw; Andrew Civitello; Biswajit Kar; Pranav Loyalka; Frederic S Resnic; Paul Teirstein; Raj Makkar; Igor F Palacios; Michael Collins; Jeffrey Moses; Karim Benali; William W O'Neill Journal: JACC Cardiovasc Interv Date: 2009-02 Impact factor: 11.195
Authors: Sarah B Cairo; Mary Arbuthnot; Laura Boomer; Michael W Dingeldein; Alexander Feliz; Samir Gadepalli; Christopher R Newton; Pramod Puligandla; Robert Ricca; Peter Rycus; Adam M Vogel; Guan Yu; Ziqiang Chen; David H Rothstein Journal: Pediatr Crit Care Med Date: 2018-10 Impact factor: 3.624
Authors: Keshava Rajagopal; Steven P Keller; Bindu Akkanti; Christian Bime; Pranav Loyalka; Faisal H Cheema; Joseph B Zwischenberger; Aly El Banayosy; Federico Pappalardo; Mark S Slaughter; Marvin J Slepian Journal: ASAIO J Date: 2020-06 Impact factor: 2.872
Authors: Keshava Rajagopal; Steven P Keller; Bindu Akkanti; Christian Bime; Pranav Loyalka; Faisal H Cheema; Joseph B Zwischenberger; Aly El Banayosy; Federico Pappalardo; Mark S Slaughter; Marvin J Slepian Journal: Circ Heart Fail Date: 2020-05-01 Impact factor: 8.790